CLINICAL_TRIALS
trial_result
· 2016-07-25
Clinical Trial Update: A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA) [Phase 2]
Summary
A Phase 2 trial of AK106-001616 in rheumatoid arthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Asahi Kasei Therapeutics Corporation | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED